SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,370 | -82.9% | 266,392 | +12.9% | 0.00% | – |
| Q2 2023 | $282,992 | +180.5% | 236,048 | +61.5% | 0.00% | – |
| Q1 2023 | $100,878 | -63.0% | 146,200 | -63.5% | 0.00% | – |
| Q4 2022 | $272,634 | -48.6% | 401,031 | -22.0% | 0.00% | – |
| Q3 2022 | $530,000 | -15.1% | 514,171 | -44.0% | 0.00% | – |
| Q2 2022 | $624,000 | -9.8% | 918,005 | +11.3% | 0.00% | – |
| Q1 2022 | $692,000 | -59.8% | 824,755 | -21.8% | 0.00% | – |
| Q4 2021 | $1,720,000 | +97.7% | 1,055,032 | +192.0% | 0.00% | – |
| Q3 2021 | $870,000 | -39.9% | 361,318 | -34.1% | 0.00% | – |
| Q2 2021 | $1,447,000 | -64.9% | 548,240 | -33.6% | 0.00% | – |
| Q1 2021 | $4,122,000 | +24147.1% | 825,987 | +4433.7% | 0.00% | – |
| Q3 2019 | $17,000 | – | 18,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |